Australian biotechs front up at BIO 2011
Monday, 27 June, 2011
The BIO International Convention has long been an institution in the annual life sciences calendar. The latest event, BIO 2011, kicks off today in Washington DC.
The event features keynotes and sessions from policymakers, scientists and CEOs, including a keynote luncheon with former British Prime Minister Tony Blair.
Australia will be fielding a significant contingent, with many antipodean institutions and companies, including:
- Advangen International
- AIMEDICS
- AusBiotech
- Australian Trade Commission
- Bio Innovation SA (Government of South Australia)
- Biopharmaceuticals Australia
- Cellmid
- Clinical Network Services (CNS)
- Datapharm Australia
- Department Of Commerce Western Australia
- DSM Biologics Queensland
- Government of Queensland
- Government of Victoria - Melbourne, Australia
- Griffith University, Griffith Enterprise
- Institute for Molecular Bioscience
- Invetech
- JDJ Bioservices
- Life Sciences Queensland (LSQ)
- Linear Clinical Research
- NICTA
- Novotech
- Nucleus Network
- Office of Trade, Business & Industry NSW
- Phylogica
- Q-Pharm
- QCTN/Burrill & Company Partnership
- Queensland Clinical Trials Network (QCTN)
- QRxPharma
- Queensland University of Technology
- Radpharm Scientific
- TetraQ
- UniQuest
- Vicibio
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
